COMMUNIQUÉS West-GlobeNewswire

Rhizen Pharmaceuticals S.A. receives FDA orphan-drug designation for Tenalisib (RP6530) for treatment of peripheral T-cell lymphoma (PTCL)

22/12/2017 - 14:00

La Chaux-de-Fonds, Switzerland, Dec. 22, 2017 (GLOBE NEWSWIRE) -- Rhizen Pharmaceuticals S.A., today announced that the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation for the active moiety [...]

Agile Therapeutics, Inc. Receives a Complete Response Letter from the FDA for Twirla® (AG200-15) for the Prevention of Pregnancy

22/12/2017 - 13:30

PRINCETON, N.J., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ: AGRX ), a women’s healthcare company, today announced that the U.S. Food and Drug Administration (FDA) issued a complete response [...]

RedHill Biopharma Announces Initiation of Phase IIa Study with ABC294640 (YELIVA®) for Cholangiocarcinoma at Mayo Clinic and MD Anderson

22/12/2017 - 13:00

YELIVA ® , a proprietary, first-in-class SK2 inhibitor, was granted FDA Orphan Drug designation for the treatment of cholangiocarcinoma Cholangiocarcinoma (bile duct cancer) is a highly lethal malignancy for which there [...]

Avivagen Inc. Announces the Granting of Options

22/12/2017 - 12:30

OTTAWA, Dec. 22, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSX-V: VIV ) (OTC Pink:CHEXF) (“ Avivagen ” or the “ Company ”), a life sciences innovation company with a series of patent protected products that support and [...]

Saniona AB: Notice of extraordinary shareholders' meeting in Saniona AB

22/12/2017 - 08:16

PRESS RELEASE December 22, 2017 The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail . The shareholders in [...]

Serendipity Ixora proposes distribution of its Xbrane shares to its shareholders, after which Serendipity Group becomes the largest shareholder in Xbrane if the distribution is executed

22/12/2017 - 08:01

Press release 2017-12-22 Xbrane Biopharma AB (publ) ("Xbrane" or "the Company") informs that the Company's largest shareholder Serendipity Ixora AB ("Serendipity Ixora"), intends to distribute all its shares in Xbrane [...]

Xbrane Biopharma largest shareholder Serendipity Group issues a credit facility of SEK 50 million to the company

22/12/2017 - 08:01

Press release 2017-12-22 Xbrane Biopharma AB (publ) ("Xbrane" or the "Company") has today got issued a credit facility from Serendipity Group AB ("Serendipity Group") of SEK 50 million (the "Credit Facility"). The [...]

Saniona AB: The Nomination Committee of Saniona Proposes Election of Two Additional Members of the Board of Directors

22/12/2017 - 08:01

PRESS RELEASE December 22, 2017 Saniona, a leading biotech company in the field of ion channels, today announced that its Nomination Committee comprised of Søren Skjærbæk appointed by Jørgen Drejer, John Haurum [...]

Novartis' combination therapy Tafinlar® + Mekinist® granted FDA Priority Review for the adjuvant treatment of stage III BRAF V600 mutation-positive melanoma

22/12/2017 - 07:16

Priority Review designation based on Phase III study showing 53% reduction in risk of recurrence or death with Tafinlar + Mekinist, as compared to placebo[1] Improvements observed in key secondary endpoints including [...]

Bank of America Merrill Lynch Investment Banking Veteran Joins Hua Medicine as CFO

22/12/2017 - 01:00

SHANGHAI, China, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Hua Medicine, a leading clinical stage biotechnology company based in Shanghai, announced George Lin, a seasoned investment banker in the U.S. and Asia, joins Hua [...]

DiaMedica Therapeutics Announces Results of Annual General and Special Meeting of Shareholders

22/12/2017 - 00:48

MINNEAPOLIS, Dec. 21, 2017 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (TSX-V: DMA ) (OTCQB:DMCAF) (the “ Company ”), today announced that at its Annual General and Special Meeting (the “ Meeting ”) of shareholders [...]

La Jolla Pharmaceutical Company Announces FDA Approval of Giapreza™ (angiotensin II)

22/12/2017 - 00:15

Giapreza increases blood pressure in adults with septic or other distributive shock La Jolla to host conference call and webcast at 8:30 a.m. EST on December 22, 2017 SAN DIEGO, Dec. 21, 2017 (GLOBE NEWSWIRE) -- La [...]

Forward Pharma Files Final Brief in its Appeal of the U.S. Patent Interference to the Federal Circuit

21/12/2017 - 23:00

COPENHAGEN, Denmark, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ: FWP ) (“Forward” or the “Company”) today announced the filing of its reply brief to the U.S. Court of Appeals for the Federal Circuit ( [...]

Akers Biosciences Announces Closing of $6,900,000 Public Offering

21/12/2017 - 22:58

THOROFARE, N.J., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company" or “Akers Bio”), a developer of rapid health information technologies, today announces the closing [...]

Proteostasis Therapeutics Announces Completion of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

21/12/2017 - 22:50

CAMBRIDGE, Mass., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (Nasdaq: PTI ), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to [...]

Humanigen Signs Definitive Agreements to Exchange Loan Obligations for Equity

21/12/2017 - 22:45

Transactions Create Biotechnology Company Focused on Immunotherapy and Oncology Lenzilumab Begins Development for Treating Key Side-Effects Associated with CAR-T BRISBANE, Calif., Dec. 21, 2017 (GLOBE NEWSWIRE) -- [...]

Integra LifeSciences to Present at the 36th Annual J.P. Morgan Healthcare Conference

21/12/2017 - 22:15

PLAINSBORO, N.J., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART ), a leading global medical technology company, today announced President and Chief Executive Officer Peter [...]

Ascendis Pharma A/S Announces Participation in 36th Annual J.P. Morgan Healthcare Conference

21/12/2017 - 22:05

COPENHAGEN, Denmark, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND ), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare [...]

Fluidigm Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

21/12/2017 - 22:05

SOUTH SAN FRANCISCO, Calif., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM ) today announced that the Compensation Committee of its Board of Directors, which is comprised entirely of independent [...]